On Monday, Immunome Inc (NASDAQ: IMNM) opened higher 10.53% from the last session, before settling in for the closing price of $11.59. Price fluctuations for IMNM have ranged from $6.93 to $30.96 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 26.27% at the time writing. With a float of $48.99 million, this company’s outstanding shares have now reached $60.05 million.
Let’s look at the performance matrix of the company that is accounted for 55 employees. In terms of profitability, gross margin is 87.4%, operating margin of -2518.49%, and the pretax margin is -2435.02%.
Immunome Inc (IMNM) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Immunome Inc is 18.42%, while institutional ownership is 79.16%. The most recent insider transaction that took place on Sep 19 ’24, was worth 230,224. In this transaction Chief Financial Officer of this company sold 14,380 shares at a rate of $16.01, taking the stock ownership to the 47,476 shares. Before that another transaction happened on Sep 19 ’24, when Company’s Officer proposed sale 14,380 for $16.01, making the entire transaction worth $230,211.
Immunome Inc (IMNM) Latest Financial update
If we go through the results of last quarter, which was made public on 6/30/2024, the company posted -0.46 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.16) by -0.3. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.55 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 26.27% per share during the next fiscal year.
Immunome Inc (NASDAQ: IMNM) Trading Performance Indicators
Check out the current performance indicators for Immunome Inc (IMNM). In the past quarter, the stock posted a quick ratio of 7.12. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 72.11.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -7.69, a number that is poised to hit -0.54 in the next quarter and is forecasted to reach -2.82 in one year’s time.
Technical Analysis of Immunome Inc (IMNM)
Immunome Inc (NASDAQ: IMNM) saw its 5-day average volume 0.49 million, a negative change from its year-to-date volume of 0.76 million. As of the previous 9 days, the stock’s Stochastic %D was 41.84%. Additionally, its Average True Range was 0.71.
During the past 100 days, Immunome Inc’s (IMNM) raw stochastic average was set at 30.31%, which indicates a significant decrease from 96.73% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 57.19% in the past 14 days, which was lower than the 67.82% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $13.58, while its 200-day Moving Average is $16.40. Nevertheless, the first resistance level for the watch stands at $13.31 in the near term. At $13.82, the stock is likely to face the second major resistance level. The third major resistance level sits at $14.77. If the price goes on to break the first support level at $11.85, it is likely to go to the next support level at $10.90. The third support level lies at $10.39 if the price breaches the second support level.
Immunome Inc (NASDAQ: IMNM) Key Stats
There are currently 60,054K shares outstanding in the company with a market cap of 777.34 million. Presently, the company’s annual sales total 14,020 K according to its annual income of -106,810 K. Last quarter, the company’s sales amounted to 2,360 K and its income totaled -36,120 K.
